The stock of Invivyd Inc (NASDAQ: IVVD) has decreased by -11.00 when compared to last closing price of 1.00. Despite this, the company has experienced a -14.42% fall in its stock price over the last five trading sessions. globenewswire.com reported 2024-11-12 that WALTHAM, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) — Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today announced that a manuscript preprint conveying data from the CANOPY Phase 3 clinical trial of pemivibart, a half-life extended investigational monoclonal antibody (mAb) for the pre-exposure prophylaxis (PrEP) of COVID-19, including long-term protection shown versus recent JN.1 sublineages at low residual titers, was uploaded to MedRxiv, and a preprint describing a novel approach for predicting mAb activity was uploaded to BioRxiv.
Is It Worth Investing in Invivyd Inc (NASDAQ: IVVD) Right Now?
Additionally, the 36-month beta value for IVVD is 0.70. There are mixed opinions on the stock, with 2 analysts rating it as a “buy,” 1 rating it as “overweight,” 1 rating it as “hold,” and 0 rating it as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for IVVD is 72.65M and currently, short sellers hold a 11.39% ratio of that float. The average trading volume of IVVD on November 14, 2024 was 465.38K shares.
IVVD’s Market Performance
IVVD stock saw a decrease of -14.42% in the past week, with a monthly decline of -6.44% and a quarterly a decrease of -14.42%. The volatility ratio for the week is 7.82%, and the volatility levels for the last 30 days are 7.26% for Invivyd Inc (IVVD). The simple moving average for the past 20 days is -8.23% for IVVD’s stock, with a -56.13% simple moving average for the past 200 days.
Analysts’ Opinion of IVVD
Many brokerage firms have already submitted their reports for IVVD stocks, with Guggenheim repeating the rating for IVVD by listing it as a “Buy.” The predicted price for IVVD in the upcoming period, according to Guggenheim is $9 based on the research report published on April 05, 2024 of the current year 2024.
Morgan Stanley, on the other hand, stated in their research note that they expect to see IVVD reach a price target of $10, previously predicting the price at $4. The rating they have provided for IVVD stocks is “Overweight” according to the report published on March 26th, 2024.
Morgan Stanley gave a rating of “Equal-Weight” to IVVD, setting the target price at $4 in the report published on December 19th of the previous year.
IVVD Trading at -10.73% from the 50-Day Moving Average
After a stumble in the market that brought IVVD to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -82.87% of loss for the given period.
Volatility was left at 7.26%, however, over the last 30 days, the volatility rate increased by 7.82%, as shares sank -9.71% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +4.69% upper at present.
During the last 5 trading sessions, IVVD fell by -14.42%, which changed the moving average for the period of 200-days by -81.98% in comparison to the 20-day moving average, which settled at $0.9698. In addition, Invivyd Inc saw -77.41% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at IVVD starting from MCGUIRE TERRANCE, who sale 112,381 shares at the price of $1.66 back on May 29 ’24. After this action, MCGUIRE TERRANCE now owns 4,688,079 shares of Invivyd Inc, valued at $186,575 using the latest closing price.
Adimab, LLC, the 10% Owner of Invivyd Inc, sale 5,000,000 shares at $3.95 during a trade that took place back on Jan 19 ’24, which means that Adimab, LLC is holding 21,687,906 shares at $19,750,000 based on the most recent closing price.
Stock Fundamentals for IVVD
Current profitability levels for the company are sitting at:
- -40.8 for the present operating margin
- 0.59 for the gross margin
The net margin for Invivyd Inc stands at -38.55. The total capital return value is set at -1.53. Equity return is now at value -96.56, with -82.73 for asset returns.
Based on Invivyd Inc (IVVD), the company’s capital structure generated 0.0 points at debt to capital in total, while cash flow to debt ratio is standing at -273.72. The debt to equity ratio resting at 0.0. The interest coverage ratio of the stock is -57.53.
Currently, EBITDA for the company is -196.62 million with net debt to EBITDA at 0.7. When we switch over and look at the enterprise to sales, we see a ratio of -7.73. The receivables turnover for the company is 1.5for trailing twelve months and the total asset turnover is 0.03. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.71.
Conclusion
In conclusion, Invivyd Inc (IVVD) has seen bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
